These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 27349385)

  • 1. Targeting microRNAs as key modulators of tumor immune response.
    Paladini L; Fabris L; Bottai G; Raschioni C; Calin GA; Santarpia L
    J Exp Clin Cancer Res; 2016 Jun; 35():103. PubMed ID: 27349385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs Reprogram Tumor Immune Response.
    Cao W; Cheng W; Wu W
    Methods Mol Biol; 2018; 1699():67-74. PubMed ID: 29086368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in the Diagnosis and Treatment of Cancer.
    Mansoori B; Mohammadi A; Shirjang S; Baradaran B
    Immunol Invest; 2017 Nov; 46(8):880-897. PubMed ID: 29058545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs: Pleiotropic Regulators in the Tumor Microenvironment.
    Yang N; Zhu S; Lv X; Qiao Y; Liu YJ; Chen J
    Front Immunol; 2018; 9():2491. PubMed ID: 30443251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of miRNAs in immune responses and immunotherapy in cancer.
    Cortez MA; Anfossi S; Ramapriyan R; Menon H; Atalar SC; Aliru M; Welsh J; Calin GA
    Genes Chromosomes Cancer; 2019 Apr; 58(4):244-253. PubMed ID: 30578699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Immune Cells by microRNAs and microRNA-Based Cancer Immunotherapy.
    Veiga RN; Zambalde ÉP; Cox L; Jucoski TS; Kohler AF; Carvalho TM; Rodrigues AC; Ludwig B; Crowley K; de Oliveira JC; Cortez MA
    Adv Exp Med Biol; 2022; 1385():75-108. PubMed ID: 36352211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications.
    Mondal P; Kaur B; Natesh J; Meeran SM
    Semin Cell Dev Biol; 2022 Apr; 124():99-113. PubMed ID: 33865701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.
    Rupaimoole R; Calin GA; Lopez-Berestein G; Sood AK
    Cancer Discov; 2016 Mar; 6(3):235-46. PubMed ID: 26865249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let-7 microRNA as a potential therapeutic target with implications for immunotherapy.
    Gilles ME; Slack FJ
    Expert Opin Ther Targets; 2018 Nov; 22(11):929-939. PubMed ID: 30328720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.
    Otmani K; Rouas R; Lewalle P
    Front Immunol; 2022; 13():913951. PubMed ID: 36189271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics.
    Gomarasca M; Maroni P; Banfi G; Lombardi G
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics.
    Smolle MA; Calin HN; Pichler M; Calin GA
    FEBS J; 2017 Jul; 284(13):1952-1966. PubMed ID: 28132417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapies.
    Gandellini P; Doldi V; Zaffaroni N
    Semin Cancer Biol; 2017 Jun; 44():132-140. PubMed ID: 28344166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathways: microRNAs, cancer cells, and microenvironment.
    Berindan-Neagoe I; Calin GA
    Clin Cancer Res; 2014 Dec; 20(24):6247-53. PubMed ID: 25512634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy.
    Romano G; Kwong LN
    Cancer Metastasis Rev; 2018 Mar; 37(1):45-53. PubMed ID: 29270700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs, Melanoma and Microenvironment: An Intricate Network.
    Romano G; Kwong LN
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29112174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-mediated cancer metastasis regulation via heterotypic signals in the microenvironment.
    Ma H; Liang C; Wang G; Jia S; Zhao Q; Xiang Z; Li Y; Cho WC; Pestell RG; Liang L; Yu Z
    Curr Pharm Biotechnol; 2014; 15(5):455-8. PubMed ID: 24846069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of microRNAs in cancer associated fibroblasts of gastric cancer.
    Yan Y; Wang R; Guan W; Qiao M; Wang L
    Pathol Res Pract; 2017 Jul; 213(7):730-736. PubMed ID: 28554761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.
    Kohlhapp FJ; Mitra AK; Lengyel E; Peter ME
    Oncogene; 2015 Nov; 34(48):5857-68. PubMed ID: 25867073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.